Sign in

CIK 0000727510

  • Non-accelerated filer
  • Smaller reporting company

Viskase Holdings, Inc.

Sign in to watch
Ticker
VISK
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222372868
Phone
+1 630-874-0700
Business address
333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
Former names
ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2008-05-09 Renfro Phillip M Director Sale −3,600 $9.45 $34K 1,911
2008-05-09 Renfro Phillip M Director Sale −1,887 $9.47 $18K 24
2008-01-17 TOOMAN CRAIG A EVP, FINANCE, CFO Grant or award +55,000 109,500
2008-01-17 HORAK IVAN D EVP, R&D, Chief Scientific Ofc Grant or award +55,000 91,000
2008-01-17 BUCHALTER JEFFREY H Chairman, CEO & President Grant or award +200,000 403,234
2008-01-17 Davit Paul Stephen EVP, Human Resources Grant or award +10,000 50,656.17
2008-01-17 del Campo Ralph EVP, Technical Operations Grant or award +55,000 114,156.14
2008-01-02 SALISBURY ROBERT C Director Grant or award · Stock Option (Right to Buy) +21,227 21,227

Page 25 of 25 · 488 trades